Accrued Expenses

9 Months Ended

Sep. 30, 2024

Accrued Expenses

Accrued Expenses

6. Accrued Expenses

Accrued expenses consisted of the following (in thousands):

	September 30,		December 31,
	2024		2023
Payroll and related costs	$	2,129	$	7,746
Clinical trials and drug development		3,867		4,701
Accrued license agreement payment		—		4,000
Professional fees		858		1,236
Selling and commercial liabilities		6,106		3,901
Short-term lease liabilities		804		774
Other		395		501
Total accrued expenses	$	14,159	$	22,859